AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 277: L573-L579, 1999;
1040-0605/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hattori, N.
Right arrow Articles by Simon, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hattori, N.
Right arrow Articles by Simon, R. H.
Vol. 277, Issue 3, L573-L579, September 1999

Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung

Noboru Hattori, Thomas H. Sisson, Yin Xu, Tushar J. Desai, and Richard H. Simon

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan 48109-0642

In vitro studies have demonstrated that the binding of urokinase-type plasminogen activator (uPA) to its cell surface receptor (uPAR) greatly accelerates plasminogen activation. However, the role of uPAR in clearing abnormal fibrin deposits from the lung is uncertain. Knowing that uPA binding to uPAR is species specific, we used adenoviral vectors to transfer human or murine uPA genes into human or mouse epithelial cells in vitro and to mouse lungs in vivo. By measuring degradation of fluorescein-labeled fibrin, we found that uPA lysed fibrin matrices more efficiently when expressed in cells of the same species. A monoclonal antibody that blocks the binding of human uPA to human uPAR suppressed fibrin degradation by human cells expressing human uPA but not murine uPA. Importantly, 3 days after intratracheal delivery of the vectors, mice receiving murine uPA transgenes degraded fibrin matrices formed within their air spaces more efficiently than animals transduced with human uPA genes. These results show that uPA bound to uPAR increases the efficiency of fibrinolysis on epithelial cell surfaces in a biologically relevant fashion.

fibrinolysis; gene therapy; inflammation


This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. H. Sisson, K. E. Hanson, N. Subbotina, A. Patwardhan, N. Hattori, and R. H. Simon
Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice
Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1023 - L1032.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. IDELL, A. P. MAZAR, P. BITTERMAN, S. MOHLA, and A. L. HARABIN
Fibrin Turnover in Lung Inflammation and Neoplasia
Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 578 - 584.
[Full Text]

Home page
 BloodHome page
K. Bdeir, J.-C. Murciano, J. Tomaszewski, L. Koniaris, J. Martinez, D. B. Cines, V. R. Muzykantov, and A. A.-R. Higazi
Urokinase mediates fibrinolysis in the pulmonary microvasculature
Blood, September 1, 2000; 96(5): 1820 - 1826.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online